enabling replicative immortality Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

what are the triggers for senescence?

A

accumulation of DNA damage with time

strong acute damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is ‘the hayflick limit’?

A

the idea that normal human cells will divide a set number of times before they stop (normal human fibroblast cell lines will divide for 50-60 population doublings before viability begins to decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is senescence?

A

a terminal differentiation state in which metabolically active cells are permanently and irreversibly arrested, with distinct morphological changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the pathways to senescence?

A
  • replicative senescence (telomere damage)

- stress induced premature senescence (oxidative stress, activation of oncogenes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are telomeres?

A

repetitive DNA sequences (TTAGGG) that cap the chromosomes and protect their ends from erosion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

list markers of senescence

A
1- growth arrest 
2- SA-Bgal
3- DNA damage foci
4- heterochromatin foci 
5- p16INK4a
6- senescence associated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

list markers of senescence

A
1- growth arrest 
2- SA-Bgal
3- DNA damage foci
4- heterochromatin foci 
5- p16INK4a
6- senescence associated secretory phenotype
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is ‘senescence associated B-gal’?

A

‘hallmark’ of senescence

most widely used senescence marker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are senescence associated heterochromatin foci?

A

-senescence is associated with large scale chromatin reorganisation

characterised by enrichment of repressive marks such as trimethylated H3K9 and heterochromatic protein 1

result of spatial reorganisation of pre-existing repressive marks rather than global changes in histone methylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is meant by the senescence associated secretory phenotype (SASP)?

A

senescence is mediated by secretory factors e.g. inflammatory cytokines, chemokine, ECM proteases, growth factors and other signalling molecules secreted by senescent cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what functions are associated with the SASP?

A
  • immune evasion
  • immune surveillance
  • wound healing acceleration
  • tumour promotion
  • cellular plasticity
  • tissue dysfunction
  • senescence re-enforcement
  • paracrine senescence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

in what way could senescence promote cancer?

A

SASP stimulates cell growth and transformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is meant by the term: antagonistic pleiotropy?

A

senescence controls more than one phenotypic trait in an organism (pleiotropy), at least one of them is beneficial and at least one is detrimental to the organisms fitness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

give examples of senescence related diseases?

A
  • glaucoma
  • macular degeneration
  • disc degeneration
  • brain aneurysm
  • AD
  • parkinsons
  • obesity
  • IBD
  • sarcopenia
  • liver fibrosis
  • hypertension
  • COPD
  • renal disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is therapy induced senescence?

A

radio/chemotherapy stresses the cells, some die, some senescence.
the senescent cancer cells survive -> tumour relapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how do cancer cells enable replicative immortality?

A

telomerase expression

inhibition of p53 and Rb

17
Q

what sort of therapies could be used to target aberrant senescence?

A

telomerase inhibitors

  • SASP inhibitors (senostatics)
  • anti-senescent drugs (senolytics)
  • reactivate tumour suppressor pathways